BESSEMER VENTURE PARTNERS

About Bessemer Venture Partners

Venture capital investment firm

Recent News about Bessemer Venture Partners

• Sarvam AI becomes $1.5B unicorn to build sovereign agentic AI

  On June 16, 2026, multiple Indian outlets reported that Bengaluru-based Sarvam AI has closed a $234 million first tranche of its Series B at a $1.5 billion valuation, led by HCLTech with participation from Bessemer Venture Partners, Khosla Ventures and Peak XV. A Moneycontrol interview the same day detailed that Sarvam plans to use the round to scale compute, build larger models, open a San Francisco office and focus on enterprise-grade agentic AI.

  Source: ABP Live2026-06-16T06:34:00.000Z

• Sarvam founders double down on sovereign, agentic AI after $234M raise

  On June 16, 2026, Moneycontrol published an interview with Sarvam AI’s founders following the startup’s recent $234 million Series B round at a $1.5 billion valuation. The founders outlined plans to build larger sovereign Indian language models, expand enterprise offerings, and invest in agentic AI capabilities as Anthropic’s export ban reignites sovereignty debates.([moneycontrol.com](https://www.moneycontrol.com/news/business/startup/sarvam-is-deeply-interested-in-solving-for-agentic-ai-enterprise-business-scaling-rapidly-founders-pratyush-kumar-vivek-raghavan-13950490.html))

  Source: Moneycontrol2026-06-16T03:19:00.000Z

• DriveNets secures $410M Series D to scale AI networking

  On June 1, Israel-based networking company DriveNets announced a $410 million Series D round, bringing its total funding to $1 billion. The financing, led by Bessemer Venture Partners and Atreides Management with participation from AMD, Red Dot Capital, Pitango and D1 Capital, will expand DriveNets’ Ethernet fabric for large-scale AI clusters.

  Source: PR Newswire2026-06-01T20:39:00.000Z

• Trajectory lands $15M seed to build continual-learning AI layer

  A group of ex‑Google DeepMind, Apple, OpenAI and Meta Superintelligence Labs researchers launched Trajectory on May 27, 2026 with $15 million in seed funding at a $115 million post-money valuation. The startup aims to provide infrastructure so enterprise AI models continuously improve from real-world user interactions rather than remaining static after training.

  Source: WIRED2026-05-27T17:00:00.000Z

• Unframe raises $50m Series B to scale enterprise AI delivery

  On May 26, 2026 Citybiz reported that Cupertino‑based Unframe raised a $50 million Series B led by Highland Europe, with participation from existing investors including Bessemer and Craft. The company says it has surpassed $100 million in total contract value in 12 months by helping enterprises deploy customised AI solutions through its managed platform.

  Source: Citybiz2026-05-26T13:07:27.404Z

• Sarvam AI targets $300–350M round at $1.5B valuation with Nvidia and Amazon

  On April 3, 2026, Bloomberg-sourced reports in Indian and Chinese media said Bengaluru-based Sarvam AI is close to raising $300–350 million at a $1.5–1.55 billion valuation. Bessemer Venture Partners is expected to lead the round, with Nvidia, Amazon and Prosperity7 Ventures also likely to participate; the deal could close as early as next week.

  Source: The Economic Times2026-04-03T04:39:41.000Z

• Sarvam AI nears $1.5B valuation with landmark India-focused AI funding round

  NDTV, citing people familiar, reported on April 3, 2026 that Bengaluru-based Sarvam AI is close to raising $300–$350 million at a valuation of about $1.5–$1.55 billion. The round is expected to be led by Bessemer Venture Partners with Nvidia, Amazon and Prosperity7 Ventures also participating, backing Sarvam’s multilingual and agentic AI models for 22 Indian languages.

  Source: NDTV (Bloomberg syndicated)2026-04-03T03:12:00.000Z

• Converge Bio secures $25M Series A for GenAI drug discovery lab

  Generative AI drug discovery startup Converge Bio, with offices in Boston and Tel Aviv, has raised a $25 million Series A round led by Bessemer Venture Partners. The funding, reported on January 17, 2026, will scale its generative AI platform for antibody design, protein yield optimization, and biomarker discovery after an earlier $5.5 million seed round.

  Source: Next Unicorn2026-01-17T14:11:29.336Z